(R)-2-(2-(DIPHENYLPHOSPHINO)PHENYL)-4,5-DIHYDRO-4-PHENYLOXAZOLE, 98%, 250mg

GC capillary column ROTI®Cap-1701, 15 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Pyrrolidin-2-ylphosphonic acid hydrochloride, 70%, 1g

(S)-2-((S)-2-(tert-butoxycarbonylamino)-3-methylbutanamido)propanoic acid, 95.0%, 25g

4-Amino-3-formylpyridine, 98.0%, 25g

1,4-Bis-[4-(3-acryloyloxypropyloxy)benzoyloxy]-2-methylbenzene, 98%, 25g

1-Phenyl-2,5,8,11,14-pentaoxahexadecan-16-ol, 98.0%, 25g

Methyltriethoxysilane, 98%, 25g

Methyl 3-(chloromethyl)-4-methoxybenzoate, 95.0%, 1g

Thiazolidin-2-one, 95.0%, 1kg

4-nitroaniline, min. 98.5%, for synthesis, 500 g, plastic packaging.

4-Methyl-3-(morpholine-4-sulfonyl)-phenylamine, 250mg

Oxcarbazepine>98.0%(HPLC)(N)25g